Gaps in Recognition and Evaluation of Incidentally Identified Hepatic Steatosis

Digestive Diseases and Sciences

Volumn 60, Issue 2, 2015, Pages 333-338

  Wright, Andrew P ^a,c   Desai, Amit P ^b   Bajpai, Surabhi ^a,c   King, Lindsay Y ^a,c   Sahani, Dushyant V ^a,c   Corey, Kathleen E ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CT scan; Fatty liver; Imaging; Nonalcoholic steatohepatitis; Primary care; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; AMIODARONE; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; GLUCOSE; INSULIN; METHOTREXATE; TAMOXIFEN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; FATTY LIVER; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEPATITIS C; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; INCIDENTAL FINDING; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD; PRIORITY JOURNAL; ABDOMINAL RADIOGRAPHY; AGED; BIOPSY; DOCUMENTATION; LIVER CIRRHOSIS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PATIENT REFERRAL; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PROCEDURES; PROGNOSIS; RADIOGRAPHY; RADIOLOGY INFORMATION SYSTEM; RECOGNITION; RISK FACTOR;

ADULT; AGED; BIOPSY; DOCUMENTATION; FEMALE; HUMANS; INCIDENTAL FINDINGS; LIVER CIRRHOSIS; MALE; MEDICAL RECORDS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROGNOSIS; RADIOGRAPHY, ABDOMINAL; RADIOLOGY INFORMATION SYSTEMS; RECOGNITION (PSYCHOLOGY); REFERRAL AND CONSULTATION; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84921822208     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3346-5     Document Type: Article

References (9)

1. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363:1341–1350.
2. Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, Ha HK, Lee MG, Hwang S, Lee SG, Yu ES, Cho EY. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology. 2006;239:105–112.
3. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524–530 e1; quiz e60.
4. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2011;142:1592–1609.
5. Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol. 2008;49:608–612.
6. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K, Sanderson SO, Lenzi M, Adams LA, Kench J, Therneau TM, Day CP. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846–854.
7. Said A, Gagovic V, Malecki K, Givens ML, Nieto FJ. Primary care practitioners survey of non-alcoholic fatty liver disease. Ann Hepatol. 2013;12:758–765.
8. McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010;59:1265–1269.
9. Angulo P, Bugianesi E, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Barrera F, Haflidadottir S, Day CP, George J. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2013;145:782 e4–789 e4.